Doo Nam Kim

Dr. Doo Nam Kim

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
DKDoo Nam Kim
Doo Nam Kim
BTBernhard C. Thiel
Bernhard C. Thiel
TMTyler Mrozowich
Tyler Mrozowich
SHScott P. Hennelly
Scott P. Hennelly
IHIvo Hofacker
Ivo Hofacker
KSKarissa Sanbonmatsu
Karissa Sanbonmatsu
Long non-coding RNAs (lncRNAs) constitute a significant fraction of the transcriptome, playing important roles in development and disease. However, our understanding of structure-function relationships for this emerging class of RNAs has been limited to secondary structures. Here, we report the 3-D atomistic structural study of epigenetic lncRNA,Braveheart (Bvht), and its complex with CNBP (Cellular Nucleic acid Binding Protein). Using small angle X-ray scattering (SAXS), we elucidate the ensemble ofBvhtRNA conformations in solution, revealing thatBvhtlncRNA has a well-defined, albeit flexible 3-D structure that is remodeled upon CNBP binding. Our study suggests that CNBP binding requires multiple domains ofBvhtand theRHT/AGILRNA motif. We show that RHT/AGIL, previously shown to interact with CNBP, contains a highly flexible loop surrounded by more ordered helices. As one of the largest RNA-only 3-D studies, the work lays the foundation for future structural studies of lncRNA-protein complexes.

1 October 2019 in Journal of Structural Biology
Verified
Journal Article
Closed access
DKDoo Nam Kim
Doo Nam Kim
NMNigel W. Moriarty
Nigel W. Moriarty
SKSerdal Kirmizialtin
Serdal Kirmizialtin
PAPavel V. Afonine
Pavel V. Afonine
BPBilly Poon
Billy Poon
KSKarissa Sanbonmatsu
Karissa Sanbonmatsu

11 March 2014 in Journal of Molecular Cell Biology
Verified
Journal Article
Open access
PDF file
RRRachel L. Redler
Rachel L. Redler
DSDavid Shirvanyants
David Shirvanyants
ODOnur Dagliyan
Onur Dagliyan
FDFeng Ding
Feng Ding
DKDoo Nam Kim
Doo Nam Kim
NDNikolay V Dokholyan
Nikolay V Dokholyan
The generation of toxic non-native protein conformers has emerged as a unifying thread among disorders such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. Atomic-level detail regarding dynamical changes that facilitate protein aggregation, as well as the structural features of large-scale ordered aggregates and soluble non-native oligomers, would contribute significantly to current understanding of these complex phenomena and offer potential strategies for inhibiting formation of cytotoxic species. However, experimental limitations often preclude the acquisition of high-resolution structural and mechanistic information for aggregating systems. Computational methods, particularly those combine both all-atom and coarse-grained simulations to cover a wide range of time and length scales, have thus emerged as crucial tools for investigating protein aggregation. Here we review the current state of computational methodology for the study of protein self-assembly, with a focus on the application of these methods toward understanding of protein aggregates in human neurodegenerative disorders.

22 February 2008 in Journal of Chemical Information and Modeling
Verified
Journal Article
Closed access
WOWon Seok Oh
Won Seok Oh
DKDoo Nam Kim
Doo Nam Kim
JJJihoon Jung
Jihoon Jung
KCKwang-Hwi Cho
Kwang-Hwi Cho
KNKyoung Tai No
Kyoung Tai No

16 April 2008 in Journal of Chemical Information and Modeling
Verified
Journal Article
Closed access
JJJihoon Jung
Jihoon Jung
NKNam Doo Kim
Nam Doo Kim
SKSu Yeon Kim
Su Yeon Kim
ICInhee Choi
Inhee Choi
KCKwang-Hwi Cho
Kwang-Hwi Cho
KNKyoung Tai No
Kyoung Tai No

15 February 2024 in Bioengineering
Verified
Journal Article
Open access
PDF file
DKDoo Nam Kim
Doo Nam Kim
AMAndrew David McNaughton
Andrew David McNaughton
NKNeeraj Kumar
Neeraj Kumar
This perspective sheds light on the transformative impact of recent computational advancements in the field of protein therapeutics, with a particular focus on the design and development of antibodies. Cutting-edge computational methods have revolutionized our understanding of protein–protein interactions (PPIs), enhancing the efficacy of protein therapeutics in preclinical and clinical settings. Central to these advancements is the application of machine learning and deep learning, which offers unprecedented insights into the intricate mechanisms of PPIs and facilitates precise control over protein functions. Despite these advancements, the complex structural nuances of antibodies pose ongoing challenges in their design and optimization. Our review provides a comprehensive exploration of the latest deep learning approaches, including language models and diffusion techniques, and their role in surmounting these challenges. We also present a critical analysis of these methods, offering insights to drive further progress in this rapidly evolving field. The paper includes practical recommendations for the application of these computational techniques, supplemented with independent benchmark studies. These studies focus on key performance metrics such as accuracy and the ease of program execution, providing a valuable resource for researchers engaged in antibody design and development. Through this detailed perspective, we aim to contribute to the advancement of antibody design, equipping researchers with the tools and knowledge to navigate the complexities of this field.